US researchers: new treatment to prevent nausea and vomiting caused by chemotherapy
US researchers: new treatment to prevent nausea and vomiting caused by chemotherapy
NEW YORK (Reuters Health) - A new study by US researchers has revealed a new drug to treat dysentery and inhibits neurotransmitters that can reduce nausea and vomiting caused by chemotherapy.
In a study published recently in the New England Journal of Medicine, US researcher Stephen Powell explained that the drug "olanzabine", approved by the US Food and Drug Administration (FDA) for use as an antipsychotic agent, prevented nausea in patients receiving chemotherapy For cancer treatment.
"We have long known that nausea and vomiting that go hand in hand with chemotherapy are a major problem and affect the quality of life of our patients," Powell said.
"The results of this new study provide physicians with a new tool to meet the needs of those who are better treated with cancer," said Powell of the Sanford Cancer Institute.
The researchers found that on the first day after treatment, 74% of the participants did not have nausea or vomiting when chemotherapy was used with the olanzapine, and continued for 5 days after chemotherapy for many patients.US researchers: new treatment to prevent nausea and vomiting caused by chemotherapy
NEW YORK (Reuters Health) - A new study by US researchers has revealed a new drug to treat dysentery and inhibits neurotransmitters that can reduce nausea and vomiting caused by chemotherapy.
In a study published recently in the New England Journal of Medicine, US researcher Stephen Powell explained that the drug "olanzabine", approved by the US Food and Drug Administration (FDA) for use as an antipsychotic agent, prevented nausea in patients receiving chemotherapy For cancer treatment.
"We have long known that nausea and vomiting that go hand in hand with chemotherapy are a major problem and affect the quality of life of our patients," Powell said.
"The results of this new study provide physicians with a new tool to meet the needs of those who are better treated with cancer," said Powell of the Sanford Cancer Institute.
The researchers found that on the first day after treatment, 74% of the participants did not have nausea or vomiting when chemotherapy was used with the olanzapine, and continued for 5 days after chemotherapy for many patients.US researchers: new treatment to prevent nausea and vomiting caused by chemotherapy
NEW YORK (Reuters Health) - A new study by US researchers has revealed a new drug to treat dysentery and inhibits neurotransmitters that can reduce nausea and vomiting caused by chemotherapy.
In a study published recently in the New England Journal of Medicine, US researcher Stephen Powell explained that the drug "olanzabine", approved by the US Food and Drug Administration (FDA) for use as an antipsychotic agent, prevented nausea in patients receiving chemotherapy For cancer treatment.
"We have long known that nausea and vomiting that go hand in hand with chemotherapy are a major problem and affect the quality of life of our patients," Powell said.
"The results of this new study provide physicians with a new tool to meet the needs of those who are better treated with cancer," said Powell of the Sanford Cancer Institute.
The researchers found that on the first day after treatment, 74% of the participants did not have nausea or vomiting when chemotherapy was used with the olanzapine, and continued for 5 days after chemotherapy for many patients.
Out Of Topic Show Konversi KodeHide Konversi Kode Show EmoticonHide Emoticon